Last $6.80 USD
Change Today +0.029 / 0.43%
Volume 866.0
MSON On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

misonix inc (MSON) Snapshot

Open
$6.78
Previous Close
$6.77
Day High
$6.80
Day Low
$6.77
52 Week High
02/7/14 - $7.17
52 Week Low
11/8/13 - $3.86
Market Cap
49.5M
Average Volume 10 Days
4.9K
EPS TTM
$-0.26
Shares Outstanding
7.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MISONIX INC (MSON)

Related News

No related news articles were found.

misonix inc (MSON) Related Businessweek News

No Related Businessweek News Found

misonix inc (MSON) Details

Misonix, Inc. designs, develops, manufactures, and markets minimally invasive ultrasonic surgical device products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery, and other surgical applications. The company offers BoneScalpel cutting system, which is used for surgical procedures of the spine and on maxillofacial procedures; SonaStar surgical aspirator that is used to emulsify and remove soft and hard tumors; and SonicOne wound cleansing and debridement system for the removal of devitalized tissue and fibrin deposits while sparing viable cells. It also markets AutoSonix ultrasound cutting and coagulating system; and Lysonix ultrasound assisted liposuction device. The company sells its products through independent direct sales persons, sales agents, and distributors. It has operations in the United States, Australia, Europe, Asia, Canada, Mexico, South America, South Africa, and the Middle East. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.

71 Employees
Last Reported Date: 09/24/13
Founded in 1959

misonix inc (MSON) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $388.9K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $243.1K
Vice President of Research & Development and ...
Total Annual Compensation: $176.0K
Compensation as of Fiscal Year 2013.

misonix inc (MSON) Key Developments

Misonix, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014

Misonix Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended March 31, 2014. Net sales for the third quarter were $4.3 million, a 42% increase, compared to $3.0 million for the same period in fiscal 2013. The increase was attributable to a 54% increase in BoneScalpel revenue to $1.7 million, a 23% increase in SonaStar revenue to $1.6 million and an 83% increase in SonicOne revenue to $728,000. The company reported net income of $0.4 million, or $0.05 diluted earnings per share, for the third quarter compared to net loss of $0.5 million, or $0.08 per basic and diluted share, for the same period in fiscal 2013. Loss from operations was $0.6 million against $1.8 million last year. Income from continuing operations before income taxes was $0.2 million against loss from continuing operations before income taxes of $0.8 million last year. Net income from continuing operations was $0.2 million or $0.02 per basic and diluted share against loss from continuing operations of $0.7 million or $0.10 per basic and diluted share last year. Revenue for the nine months ended March 31, 2014 was $11.5 million, a 4% increase, compared to $11.1 million for the same period in fiscal 2013, principally attributable to an increase of approximately $365,000 in BoneScalpel revenue, a $306,000 increase in SonicOne revenue and a $247,000 decrease in other non-core revenue. The company reported net income of $0.004 million, or $0.00 per basic and diluted share compared to net loss of $1.1 million, or $0.16 per basic and diluted share, for the same period in fiscal 2013. Loss from operations was $2.8 million against $3.1 million last year. Loss from continuing operations before income taxes was $0.2 million against loss from continuing operations before income taxes of $1.4 million last year. Net income from continuing operations was $0.3 million or $0.04 per basic and diluted share against loss from continuing operations of $1.3 million or $0.19 per basic and diluted share last year.

Misonix Inc. to Report Q3, 2014 Results on May 08, 2014

Misonix Inc. announced that they will report Q3, 2014 results at 8:05 PM, US Eastern Standard Time on May 08, 2014

Misonix Inc., Q3 2014 Earnings Call, May 08, 2014

Misonix Inc., Q3 2014 Earnings Call, May 08, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MSON:US $6.80 USD +0.029

MSON Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Integra LifeSciences Holdings Corp $47.61 USD -0.10
Johnson & Johnson $102.20 USD +0.01
Smith & Nephew PLC 1,066 GBp +7.00
Stryker Corp $80.79 USD -1.02
View Industry Companies
 

Industry Analysis

MSON

Industry Average

Valuation MSON Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.2x
Price/Book 3.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MISONIX INC, please visit www.misonix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.